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Impairment in oxygen (O2) delivery to the central nervous system (“brain”) and skeletal
locomotor muscle during exercise has been associated with central and peripheral
neuromuscular fatigue in healthy humans. From a clinical perspective, impaired tissue
O2 transport is a key pathophysiological mechanism shared by cardiopulmonary diseases,
such as chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF).
In addition to arterial hypoxemic conditions in COPD, there is growing evidence that
cerebral and muscle blood flow and oxygenation can be reduced during exercise in both
isolated COPD and CHF. Compromised cardiac output due to impaired cardiopulmonary
function/interactions and blood flow redistribution to the overloaded respiratory muscles
(i.e., ↑work of breathing) may underpin these abnormalities. Unfortunately, COPD and CHF
coexist in almost a third of elderly patients making these mechanisms potentially more
relevant to exercise intolerance. In this context, it remains unknown whether decreased
O2 delivery accentuates neuromuscular manifestations of central and peripheral fatigue
in coexistent COPD-CHF. If this holds true, it is conceivable that delivering a low-density
gas mixture (heliox) through non-invasive positive pressure ventilation could ameliorate
cardiopulmonary function/interactions and reduce the work of breathing during exercise
in these patients. The major consequence would be increased O2 delivery to the
brain and active muscles with potential benefits to exercise capacity (i.e., ↓central and
peripheral neuromuscular fatigue, respectively). We therefore hypothesize that patients
with coexistent COPD-CHF stop exercising prematurely due to impaired central motor
drive and muscle contractility as the cardiorespiratory system fails to deliver sufficient O2
to simultaneously attend the metabolic demands of the brain and the active limb muscles.
Keywords: chronic heart failure, chronic obstructive pulmonary disease, oxygenation, respiratory muscle, skeletal
muscle
INTRODUCTION
The ability to sustain daily physical activities is inextricably linked
to the integrity of the O2 transport pathway, which in turn
depends on several multi-organ interactions involving the heart
and vessels, lungs, respiratory/peripheral muscles and voluntary
and autonomic nervous systems. Impaired tissue O2 transport
Abbreviations: CaO2, arterial oxygen content; CHF, chronic heart failure; CNS,
central nervous system; COPD, chronic obstructive pulmonary disease; HR, heart
rate; ITP, intra-thoracic pressure; LFF, low-frequency fatigue; LV, left ventri-
cle; NIPPV, non-invasive positive pressure ventilation; NIRS, near-infrared spec-
troscopy; PaCO2, arterial partial pressure of carbon dioxide; Palv, alveolar pressure;
PaO2, arterial partial pressure of oxygen; PEEPi, intrinsic positive end-expiratory
pressure; PPL, pleural pressure; PTM, transmural pressure; Q˙t, cardiac output; RV,
right ventricle; SV, stroke volume; SVR, systemic vascular resistance; TMS, tran-
scranial magnetic stimulation; VA, maximal voluntary activation; V˙O2, oxygen
uptake; V˙O2max, maximal oxygen uptake; V˙/Q˙, ventilation-perfusion relationship
due to altered perfusive and/or diffusive mechanisms are key
pathophysiological abnormalities shared by two common car-
diopulmonary diseases: chronic obstructive pulmonary disease
(COPD) and chronic heart failure with reduced left ventricular
ejection fraction (CHF). Unfortunately, COPD and CHF coexist
in approximately 1 out of 3 elderly patients with a primary diag-
nosis of either disease (Rutten et al., 2005). Despite being a leading
cause of disability and mortality worldwide (Boudestein et al.,
2009), the pathophysiological consequences of the COPD-CHF
overlap have been grossly overlooked in the medical literature.
Respiratory-mechanical (e.g., lung hyperinflation and
increased intra-thoracic pressures) and gas-exchange (hypox-
emia) abnormalities are known to impair the cardiac output (Q˙t)
response (Chiappa et al., 2008) and its distribution (Borghi-Silva
et al., 2008a) during exercise in advanced COPD. On the other
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hand, impaired lung perfusion and interstitial edema decrease
lung diffusing capacity (Guazzi et al., 2005) and increase the
work of breathing and thus respiratory muscle metabolic demand
(Narkiewicz et al., 1999; Ponikowski et al., 2001) in patients with
CHF. Resultant impairments in peripheral muscle O2 delivery
increase the respiratory drive through afferent stimulation from
intra-muscle type III and IV receptors, which further raises the
ventilatory requirements to exertion in both COPD (Gagnon
et al., 2012) and CHF (Piepoli et al., 1996). Moreover, fatiguing
contractions of the diaphragm in both diseases might elicit a
sympathetic-mediated metaboreflex and further reduce limb
muscle blood flow to the working peripheral muscles (Amann,
2011; Dempsey et al., 2006). Altogether, these abnormalities are
expected to be additive in patients with COPD-CHF overlap and
may lead to critical reductions in O2 delivery (i.e., “hypoxic” and
“ischemic” hypoxia) under the stress of physical activities. The
consequences of derangements in O2 delivery are particularly
relevant to tissues requiring a fine-tune balance between O2
delivery and utilization during exercise, such as the central
nervous system (CNS) and the active skeletal muscles. Despite
these previous considerations, however, it remains unknown
whether in patients with COPD-CHF overlap (1) decreased
O2 delivery leads to deficits in cerebral and active limb muscle
oxygenation and, if this shows to be the case, (2) whether those
deficits accentuate neuromuscular manifestations of central and
peripheral fatigue, respectively.
PERIPHERAL AND CENTRAL NEUROMUSCULAR FATIGUE
Muscle fatigue can be defined as a reversible reduction in the
maximal voluntary force or power of a single muscle or mus-
cle group whether or not the task can be sustained (Gandevia,
2001). Neuromuscular fatigue can originate at different levels of
the motor pathway and is usually divided into central and periph-
eral components. Peripheral fatigue is produced by phenomena at
or distal to the neuromuscular junction. It can be demonstrated
by a reduction in force evoked by peripheral supramaximal nerve
stimulation in the relaxed potentiated muscle. In some cases,
mechanisms related to peripheral fatigue may not explain the
entire fatigue-related decrease in maximal voluntary force and
some fatigue can arise frommodifications within the CNS (Millet
and Lepers, 2004). Central fatigue is defined as a progressive fail-
ure to voluntarily activate the muscle which can originate at the
spinal and/or supraspinal levels. Interestingly, the peripheral and
central components of muscle fatigue are intrinsically related
given that recruitment of peripheral motoneurons depends on
descending drive from supraspinal sites, whereas central drive is
modulated by a combination of excitatory and inhibitory reflex
inputs from peripheral muscles, joints, tendons, and cutaneous
afferents (Millet et al., 2011).
Peripheral changes can be investigated by stimulating the
muscle in the relaxed state before, during and after the fatigu-
ing exercise. A single evoked stimulus allows measurements of
mechanical (twitch) and electromyographic (M-wave) responses.
In order to fully activate the muscles under scrutiny, it is cru-
cial to use a stimulation (electrical or magnetic) of supramaximal
intensity. Of note, forceful voluntary contractions before stimu-
lation are required to avoid the potential bias of exercise-induced
potentiation when assessing fatigue (Millet et al., 2011). Different
types of stimuli can be evoked to noninvasively investigate
(i) neuromuscular propagation of action potentials along the
sarcolemma (M-wave, high-frequency fatigue), (ii) excitation–
contraction coupling (low-frequency fatigue; LFF) and (iii)
intrinsic force (high-frequency stimulation at supramaximal
intensity). LFF is the most common type of peripheral fatigue
associated with reductions in muscle O2 delivery (Amann et al.,
2006a; Katayama et al., 2007) and is characterized by slow recov-
ery associated with impairments in the excitation–contraction
coupling. LFF is particularly deleterious to patients’ tolerance to
exertion as it might last for many hours after induction (Edwards
et al., 1977), thus limiting the capacity to perform repetitive
tasks.
Maximal voluntary activation (VA), as estimated by twitch
interpolation (Merton, 1954), is the most conventional approach
to assess central fatigue occurring during exercise. This maneuver
consists of a supramaximal stimulation of a peripheral nerve to
artificially generate action potentials during a maximal voluntary
contraction. If lower motoneurons are not fully recruited during
the maximal voluntary contraction, or are not firing fast enough,
then the evoked stimulus will generate additional force, termed
superimposed twitch. The ratio between the superimposed twitch
and a potentiated twitch elicited in the relaxed muscle allows the
quantification of VA. A decrease in VA during or after sustained
contractions suggests reduced motor drive that originates at or
above the stimulation site on the axons of the lower motoneu-
rons (i.e., at the spinal and/or supraspinal levels; central fatigue).
Transcranial magnetic stimulation (TMS) is an alternative, non-
invasive method to assess neuromuscular function by stimulating
directly the motor cortex. It has been shown that VA can also
be examined with TMS, thus allowing the description of the
supraspinal component of central fatigue (Todd et al., 2003).
EFFECTS OF O2 DELIVERY ON PERIPHERAL AND CENTRAL
FATIGUE IN HEALTH
Changes in O2 delivery may affect muscular performance and the
rate of development of both central and peripheral fatigue (as
reviewed by Amann and Calbet, 2008). Blunted O2 delivery dur-
ing exercise has been shown to accentuate, while augmented O2
delivery has been demonstrated to reduce, the rate of develop-
ment of peripheral fatigue during isolated as well as whole-body
exercise in healthy subjects. For instance, measurement of quadri-
ceps twitch force evoked by magnetic femoral nerve stimulation
before and after intermittent submaximal isometric contractions
under normoxic and hypoxic conditions showed greater periph-
eral fatigability in hypoxia (Katayama et al., 2007). A cycling bout
of similar absolute workload and duration also induced greater
impairment of quadriceps contractility in hypoxia compared to
normoxia (Amann et al., 2006a). Accelerated development of
peripheral fatigue under hypoxic conditions has also been shown
for both the inspiratory and expiratory muscles using cervical and
thoracic magnetic stimulation before and after isocapnic hyper-
pnea (Verges et al., 2010). Changes in intracellular metabolism
and the rate of accumulation of metabolites related to impair-
ments in excitation-contraction coupling (e.g., H+, inorganic
phosphates) are thought to underlie the rapid development of
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peripheral muscle fatigue with reduced O2 delivery (Amann and
Calbet, 2008).
The exacerbation of central fatigue with reduced cerebral
O2 delivery during whole-body exercise in healthy subjects has
been recently demonstrated by Goodall et al. (2012). Endurance-
trained cyclists exercised at ∼80% of their normoxic maximum
power in both normoxia and hypoxia conditions. Exercise time to
exhaustion was halved in hypoxia versus normoxia. Post-exercise
peripheral fatigue assessed by femoral nerve stimulation did not
differ while supraspinal fatigue assessed by transcranial stimula-
tion was larger in hypoxia compared to normoxia. Furthermore,
the post-exercise VA and the level of cerebral oxygen delivery dur-
ing exercise were positively correlated, suggesting that increased
central fatigue during whole-body hypoxic exercise resulted from
impaired cerebral O2 availability.
It has also been proposed that sensory afferent feedback from
the fatiguing muscles to the CNS may be a key modulator of
central motor drive and, therefore, exercise performance. This
suggests a link between peripheral (i.e., biochemical changes
within the active muscle) and central (i.e., reductions in cen-
tral motor drive to the working muscle) fatigue (Amann and
Dempsey, 2008; Amann, 2011). In this sense, the magnitude
of the inhibitory neural feedback is proportional to the rate of
development of peripheral locomotor muscle fatigue. Given that
the latter is highly sensitive to muscle O2 delivery, an increased
rate of peripheral fatigue development during exercise in hypoxia
would act as a dose-dependent trigger of central fatigue. This is
supported by the similar levels of peripheral quadriceps fatigue
observed after cycling time trials performed with various arte-
rial oxygenation levels in healthy subjects (Amann et al., 2006b).
This mechanism may, however, not apply entirely to conditions
of severe hypoxia which lead to critically low levels of brain oxy-
genation. Under these circumstances, the direct effect of severe
hypoxia on the brain and central motor drive may predominate
over the inhibitory effects of somatosensory afferent feedback
(Verges et al., 2012). Therefore, moderate hypoxia may limit
exercise performance mainly by accelerating the rate of periph-
eral fatigue development, while severe hypoxia may limit exercise
tolerance primarily due to impaired cerebral oxygenation and
subsequent central fatigue.
RESPIRATORY-LOCOMOTOR MUSCLE INTERACTIONS AND
O2 DELIVERY IN HEALTH
Hyperventilation during heavy sustained exercise (e.g., 85%max-
imal oxygen consumption, V˙O2max) causes substantial increases
in respiratory muscle work, possibly leading to diaphragm and
expiratory muscle fatigue (Dempsey et al., 2006). Accumulation
of metabolites in these muscles stimulates group IV phrenic affer-
ents, which in turn can increase sympathetic vasoconstrictor
activity in the active locomotor limbs via a supraspinal reflex
(St Croix et al., 2000). In this context, a competitive relation-
ship between respiratory and active locomotor muscle for limited
Q˙t ensues and possibly results in redistribution of blood flow
(i.e., ↑blood flow to respiratory muscles a ↓blood flow to active
locomotor muscles) (Harms et al., 1997).
The competition for blood flow between respiratory and active
lower limbmuscles and the development of peripheral locomotor
muscle fatigue independent of changes in CaO2 have been inves-
tigated in healthy subjects during high intensity cycling exercise at
similar work rates, duration of exercise, and CaO2 levels (Harms
et al., 1997; Romer et al., 2006; Amann et al., 2007). When an
exercise trial was performed with a mechanical ventilator (thus
reducing inspiratorymuscle pressure output by up to 70%), active
limb blood flow was increased by ≥5% and leg V˙O2 by 3%
compared with the control condition without ventilatory assis-
tance (Harms et al., 1997). Moreover, exercise-induced peripheral
quadriceps fatigue (assessed by femoral nerve stimulation) was
reduced by 30% with the mechanical ventilator compared with
control when both trials were performed in normoxia (Romer
et al., 2006), and by over 35% when both trials were performed
in acute hypoxia (Amann et al., 2007). In contrast, enhancing
inspiratory muscle work by about 80% with inspiratory resistive
loading reduced active limb blood flow by over 10% compared
with control, which approximately doubled the amount of post-
exercise quadriceps muscle fatigue (Romer et al., 2006). It should
be noted that, in healthy subjects, changes in limb blood flow
induced by modifying the work of breathing and the subsequent
effect on peripheral fatigue have been observed at exercise inten-
sities greater than 80% of V˙O2max (Amann et al., 2007). This
may derive from the fact that, at those intensities, exhaustive exer-
cise is capable of eliciting diaphragm fatigue and triggering the
metaboreflex as described above (Dempsey et al., 2006). These
findings thus suggest that, under hypoxemic conditions, both the
decrease in CaO2 and the increase in respiratory muscle work
(due to increased ventilation) might independently contribute to
the development of fatigue during exercise.
LUNG-HEART INTERACTIONS AND EXERCISE O2 DELIVERY
IN COPD
Expiratory flow limitation and lung hyperinflation that are only
partially reversible to bronchodilator therapy are pathophysiolog-
ical hallmarks of COPD (Langer et al., 2014). When expiratory
flow-limitation is present during resting spontaneous breath-
ing, end-expiratory lung volume is dynamically determined by
and varies with the mechanical time constant for emptying (the
product of resistance and compliance) of the respiratory system
(O’Donnell et al., 2001). As the expiratory time declines with
higher breathing frequency during exercise, a substantial amount
of inhaled air is further “trapped” in the lung—a process termed
dynamic hyperinflation (Stubbing et al., 1980; Johnson et al.,
1999; O’Donnell et al., 2001; Calverley, 2006). Breathing in rel-
atively high lung volumes during exercise is energetically and
mechanically disadvantageous as dynamic compliance decreases
and the respiratory muscles become less effective in generating
the required pressures (O’Donnell et al., 2014). Consequently,
the combination of increased ventilatory requirements (mainly
secondary to increased ventilation/perfusionmismatching and/or
hypoxemia) and abnormal dynamic ventilatory mechanics stress
the already diminished cardiopulmonary reserves during exercise.
There is also evidence that the mechanical interactions
between the cardiac and ventilatory pumps negatively affect
the cardiovascular responses to exercise in COPD (Figure 1).
Generation of relatively more negative intrathoracic pressures
during forceful inspiration to overcome the intrinsic positive
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FIGURE 1 | Schematic representation of potential negative
cardiopulmonary interactions in moderate to severe COPD. Increases in
mean intra-thoracic pressure (ITP) and large swings in pleural pressure (PPL)
may reduce venous return and right ventricular (RV) preload. High PPL
swings, compression of juxta-alveolar capillaries and hypoxic
vasoconstriction increase RV afterload and intra-cavitary pressures. The
latter occurrence, in association with extrinsic compression of the right
heart by the overdistended lungs, can impair RV relaxation and displace the
inter-ventricular septum to the left. Reduced left heart filling pressures and
dimensions may contribute to further impairments in stroke volume (SV).
Large PPL swings can also increase left ventricular (LV) afterload secondary
to high transmural pressures (PTM). Moreover, decreased aortic impedance
and augmented systemic vascular resistance (SVR) further increase LV
afterload, thus compromising cardiac output (Q˙t). Of note, the relative
contribution of each of the above factors is likely to vary according to
different phases of respiratory and cardiac cycles.
end-expiratory pressure act to increase left ventricular transmural
pressure and afterload (Ranieri et al., 1996). Forceful expiratory
muscle recruitment in the presence of expiratory flow limita-
tion may fail to produce additional flow but might increase
markedly the alveolar pressures. The latter act directly on the
blood vessels surrounding the alveolar walls, leading to mechan-
ical compression and increasing vascular pressures above the
venous pressures responsible for a normal venous return (Cassidy
and Mitchell, 1981; Scharf, 1991). In addition, as pulmonary
vascular resistance and pulmonary artery pressures rise, right ven-
tricular ejection fraction fails to increase despite progressively
higher right ventricular end-diastolic volume. In these conditions,
left ventricular end-diastolic, end-systolic and stroke volumes
may diminish because of a reduction in right ventricular ejection
fraction and/or competition for space between the two sides of the
heart within the pericardium (i.e., ventricular interdependence)
(Potter et al., 1971; Robotham et al., 1978; Nóbrega et al., 1994;
Saito et al., 1999; Stark-Leyva et al., 2004; Aliverti et al., 2005;
Miller et al., 2005, 2006). This has important clinical implications
given that the rate at which Q˙t increases from rest to exercise is
a strong determinant of peripheral O2 delivery in patients with
COPD free of heart disease (Chiappa et al., 2008).
Also interestingly, cerebral oxygenation has been found to be
impaired during exercise in COPD patients even in the absence
of hypoxemia (Oliveira et al., 2012). Strategies that were able
to reduce the work of breathing and increase Q˙t (e.g., non-
invasive positive pressure ventilation) can improve cardiopul-
monary function/interactions during exercise and ameliorate
both muscle and cerebral oxygenation profiles in these patients
(Borghi-Silva et al., 2008a; Rodrigues et al., 2013). Altogether,
these data indicate that not only Q˙t dynamics can be slowed from
rest to exercise but also that its adequate distribution to key organs
is disturbed—even in COPD patients with no evidence of CHF
(Borghi-Silva et al., 2008a; Chiappa et al., 2008). This opens the
perspective that these deleterious phenomena may be potentiated
by the presence of concomitant CHF.
HEART-LUNG INTERACTIONS AND EXERCISE O2 DELIVERY
IN CHF
It is generally accepted that reduced physical capacity with CHF is
a direct effect of the cardiovascular and neurohumoral derange-
ments that characterize the disease. Structural and functional
cardiovascular impairments affect the O2 transport pathway and
compromise the matching between O2 delivery and utilization
particularly during exercise (Poole et al., 2012). As reviewed by
Poole et al. (2012), in the presence of a failing heart, Q˙t par-
ticularly during exercise is reduced consequent to a diminished
ejection fraction, lower stroke volume (SV) and a heart rate (HR)
response that is insufficient to fully compensate for the reduced
SV. In an attempt to avoid further reductions in Q˙t (and systemic
blood pressure), there is a systemic sympathetically-mediated
vasoconstriction which, when maintained over time, impairs the
ability to distribute the reduced Q˙t to and within skeletal mus-
cle(s). Increased circulating levels of humoral mediators such
as angiotensin, vasopressin, norepinephrine and endothelin-1
contribute to global vasoconstriction. Additionally, vasodilatory
mechanisms are impaired not only due to intrinsic vascular
abnormalities (Poole et al., 2012) but also secondary to intravas-
cular sodium and water retention. Tissue O2 delivery might also
be worsened further if CHF is accompanied by anemia due to dys-
functional iron metabolism and, possibly, marked inflammation.
In addition, within skeletal muscles the capacity to utilize O2 can
be impaired in more severe patients due to reductions in mito-
chondrial oxidative enzyme activity and volume density as well as
mitochondrial dysfunction (Hirai et al., 1995; Belardinelli et al.,
1997; Kindig et al., 1999; Diederich et al., 2002; Copp et al., 2010;
Bowen et al., 2012; Poole et al., 2012).
There is also evidence that CHF patients might develop pul-
monary dysfunction including ventilation-perfusion (V˙/Q˙) mis-
match (Agostoni et al., 2006), reduced O2 diffusing capacity
(Guazzi et al., 2005) and diminished respiratory muscle strength
and endurance (Agostoni et al., 2002). While V˙/Q˙mismatch and
diffusive deficiencies may not always lead to arterial hypoxemia
in CHF, restrictive and obstructive abnormalities combined with
the sensitization of peripheral chemoreceptors (carotid bodies)
result in increased work of breathing (Narkiewicz et al., 1999;
Ponikowski et al., 2001). In addition, non-smokers with CHF
can also present with some degree of dynamic hyperinflation
during exercise, probably due to increased collapsibility of the
small airways (Ribeiro et al., 2009). It is therefore conceivable that
the concomitance of COPD could potentiate these respiratory
abnormalities in patients with CHF.
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RESPIRATORY-LOCOMOTOR MUSCLE INTERACTIONS AND
O2 DELIVERY IN COPD AND CHF DURING EXERCISE
Experimental evidence suggests that a similar competitive rela-
tionship between respiratory and active locomotor muscles for
limited Q˙t also exists in patients with COPD or CHF dur-
ing exercise. For instance, enhancement in the cardiorespiratory
adjustments to exercise through less dynamic hyperinflation (e.g.,
via bronchodilatation, Berton et al., 2010, non-invasive positive
pressure ventilation, Borghi-Silva et al., 2008a, and low density
gas breathing, Chiappa et al., 2009) accelerates active lower limb
muscle O2 delivery during metabolic transitions in patients with
moderate to severe COPD.Moreover, unloading of the respiratory
muscles via proportional assist ventilation improves peripheral
contracting muscle oxygenation in COPD patients even if Q˙t and
CaO2 remain unaltered (Borghi-Silva et al., 2008a). In line with
these findings, Amann et al. (2010) evaluated the effect of various
interventions improving arterial oxygenation and/or reducing
the work of breathing during cycling (via proportional assist
ventilation, heliox and hyperoxia) on quadriceps muscle fatigue
(assessed by femoral nerve stimulation) in COPD patients. These
interventions attenuated exercise-induced quadriceps fatigue by
one third compared to the control condition. Collectively, these
data suggest that the high susceptibility to locomotor muscle
fatigue in patients with COPD (Mador et al., 2003, 2005) is, at
least in part, attributable to arterial hypoxemia and/or to excessive
respiratory muscle work.
Similar findings have been reported in patients with CHF in
isolation: blood flow to active skeletal muscle can be reduced
not only due to lowered Q˙t and heightened sympathetic vaso-
constriction but also via a “stealing” mechanism triggered by
enhanced work of breathing during exercise (Harms et al., 1997;
Sheel et al., 2001; Iandelli et al., 2002; Dempsey et al., 2006). In
fact, respiratory muscle unloading (via proportional assist ven-
tilation) has been demonstrated to promote beneficial effects on
the oxygenation status of the exercising muscles at similar Q˙t and
CaO2 in patients with advanced CHF (Borghi-Silva et al., 2008b).
These data suggest that unloaded breathing during exercise may
minimize the “stealing” effect and lead to increased blood flow
to the active locomotor muscles of CHF patients. Nonetheless,
given that exercise has not been performed to the limit of tol-
erance nor has muscle fatigue been assessed in previous studies,
it is not possible to determine the potential contribution of this
blood flow “stealing” mechanism to the exercise capacity of these
patients.
FIGURE 2 | Schematic representation of potential implications of
abnormal pulmonary gas exchange and central hemodynamics on
central nervous system (brain) and peripheral skeletal muscle function
during exercise in combined COPD-CHF. Compromised O2 delivery to brain
and active limb muscles can occur as a consequence of impairments in gas
exchange (e.g., ↓arterial O2 pressure; PaO2) and/or decreased cardiac output
(Q˙t) and thus blood flow. A large fraction of an already reduced Q˙t can be
directed to the overloaded respiratory muscles (due to ↑work of breathing),
therefore further decreasing active limb muscle perfusion and accentuating
peripheral fatigue. Solid black lines indicate that increased afferent
information from the respiratory/peripheral muscles and/or impaired cerebral
oxygenation may decrease motor drive (i.e., central fatigue). In this context, it
is conceivable that central and peripheral fatigue potentiate each other and
contribute to early exercise cessation in coexistent COPD-CHF.
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HYPOTHESIS
Based on the body of evidence presented above, it is hypothesized
that impaired O2 delivery to both the pre-frontal cortex and active
limb muscles in coexistent COPD-CHF contributes significantly
to reduced central motor drive and accelerated peripheral muscle
fatigue development, respectively (Figure 2).
EVALUATION OF THE HYPOTHESIS
We propose to test our hypothesis by investigating the neuro-
muscular consequences (both at the central and peripheral levels)
of improved cerebral and active limb skeletal muscle O2 deliv-
ery during cycling exercise in patients with coexistent COPD-
CHF. We firstly expect that central and peripheral fatigue would
be related to impairments in cerebral and peripheral exercising
muscle oxygenation, respectively, in the control condition. We
then anticipate that these abnormalities would be simultaneously
alleviated by a strategy aimed at improving cardiopulmonary
function/interactions and reducing the work of breathing (via
non-invasive positive pressure ventilation; NIPPV). Utilization of
this intervention in combined COPD-CHF patients is expected
to slow the rate of central and peripheral fatigue development
and enhance physical capacity. We envisage that further improve-
ments in cardiopulmonary function/interactions and exercise
tolerance of COPD-CHF patients would be reached by adding
a low-density gas mixture (e.g., heliox to decrease airflow resis-
tance) to NIPPV. We also reason that further increases in cerebral
and skeletal muscle O2 delivery would be induced by progressively
increasing inspired O2 fraction in different hyperoxic heliox gas
mixtures. This would allow us to interrogate individual contribu-
tions of each of these interventions on systemic O2 delivery.
Standard cardiopulmonary responses, Q˙t and exertional rat-
ings (leg fatigue and dyspnea) will be continuously monitored
during the transition from rest to exercise. By placing gastric and
esophageal pressure catheters, inspiratory and expiratory mus-
cle force production will be assessed together with the work
of breathing. Respiratory and locomotor muscle activity will be
evaluated by surface electromyography. Patients will cycle with
near-infrared spectroscopy (NIRS) probes placed on the pre-
frontal cortex and the quadriceps muscle. An optically-dense
dye (indocyanine green) will be intermittently injected in the
venous circulation and its rate of appearance will be determined
by NIRS. This will allow the evaluation of tissue blood flow
and microvascular oxygenation (i.e., index of O2 delivery-to-
utilization (mismatching). Arterial blood gases will be assessed at
rest and during exercise. Neuromuscular function via femoral and
phrenic nerve magnetic stimulation will be evaluated before and
immediately after exercise to investigate changes in evoked elec-
tromyographic and mechanical responses of the quadriceps and
respiratory muscles.
MEDICAL CONSEQUENCES OF THE HYPOTHESIS
Despite mounting evidence that COPD-CHF overlap represents
a growing cause of physical incapacity in the western world
(Rutten et al., 2005; Boudestein et al., 2009), little is known
about the underlying mechanisms. This important gap in current
knowledge needs to be addressed to facilitate the development
of novel and effective therapeutic and rehabilitative strategies
tailored to the specific needs of these patients. Confirmation of
the study hypothesis could open the perspective that enhanc-
ing O2 delivery and/or decreasing O2 requirements within
the brain and active limb skeletal muscle positively impact
upon tolerance to exertion in patients with combined COPD-
CHF. This might set the scene for randomized controlled trials
with pharmacological (e.g., antioxidant and anti-inflammatory
agents), non-pharmacological (e.g., non-invasive ventilation,
normoxic/hyperoxic heliox) and dietary (e.g., oral nitrate supple-
mentation) interventions that might delay central and peripheral
neuromuscular fatigue development in this patient population.
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